Anamind Blog

Before you spend a dollar on any AI platform, answer these five questions. Be brutally honest. Because your score on these five determines whether AI will transform

If you are managing pharma supply chain planning in India in 2025, you are navigating a ‘perfect storm. Between the looming November 2025 DSCSA compliance

Introduction: When a Broken Chain Costs More Than a Broken Part  A few years ago, when a car broke down, the biggest worry was the

When the US announced potential tariffs on imported drugs, the tremors were felt across India’s pharma ecosystem. The headlines screamed ‘US Tariff Threats Push Indian

“AI supply chain planning across APAC is no longer a future-state ambition — it’s the operational reality that’s separating high-performing companies from those still reacting

Demand planning for the automotive industry in India has always been a game of reading signals that most planning models weren’t built to see. Monsoon

When you walk into a store and everything you need is on the shelf, it feels effortless. But behind that simplicity lies a web of

In May 2025, an understated regulatory move revealed a stark truth: Most supply chains aren’t built to flex — they fracture.  When the De Minimis Rule

Introduction: A New Trade Reality In 2025, the global pharmaceutical industry finds itself at a pivotal juncture. The United States has imposed fresh tariffs on